| pubmed-article:7278079 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:7278079 | lifeskim:mentions | umls-concept:C0027947 | lld:lifeskim |
| pubmed-article:7278079 | lifeskim:mentions | umls-concept:C0030842 | lld:lifeskim |
| pubmed-article:7278079 | lifeskim:mentions | umls-concept:C1407029 | lld:lifeskim |
| pubmed-article:7278079 | pubmed:issue | 16 | lld:pubmed |
| pubmed-article:7278079 | pubmed:dateCreated | 1981-11-24 | lld:pubmed |
| pubmed-article:7278079 | pubmed:abstractText | Eight patients treated with a total of 220-550 million U penicillin-G developed neutropenia. These cases have been compared with eight patients receiving a similar dose of pencillin-G with no adverse reactions and with eight untreated subjects. All penicillin-treated patients showed raised levels of anti-IgG antibodies and lymphocyte culture stimulation indices. These values were highest in the neutropenia group. Both of the two tests significantly discriminated the three groups. Antineutrophil antibodies could be detected in four of seven neutropenic patients with a staphylococcal-slide-assay while indirect immunofluorescence and microcytotoxicity tests failed to reveal these antibodies. The literature dealing with neutropenias induced by penicillin-G and its congeners is reviewed. We conclude that (1) penicillin-G in doses exceeding a total of 200 million U frequently induces neutropenia, (2) an immune-mediated pathogenesis a highly probable, (3) neutropenia after penicillins is different from two hither-to accepted types of this side effect, (4) sufficiently high amounts of penicillin-G intravenously always induce sensitization against this drug. | lld:pubmed |
| pubmed-article:7278079 | pubmed:language | eng | lld:pubmed |
| pubmed-article:7278079 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7278079 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:7278079 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7278079 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7278079 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7278079 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:7278079 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:7278079 | pubmed:issn | 0023-2173 | lld:pubmed |
| pubmed-article:7278079 | pubmed:author | pubmed-author:WeitzmanS ASA | lld:pubmed |
| pubmed-article:7278079 | pubmed:author | pubmed-author:von FeltenAA | lld:pubmed |
| pubmed-article:7278079 | pubmed:author | pubmed-author:de WeckA LAL | lld:pubmed |
| pubmed-article:7278079 | pubmed:author | pubmed-author:BürgiHH | lld:pubmed |
| pubmed-article:7278079 | pubmed:author | pubmed-author:SpenglerHH | lld:pubmed |
| pubmed-article:7278079 | pubmed:author | pubmed-author:WältiMM | lld:pubmed |
| pubmed-article:7278079 | pubmed:author | pubmed-author:NeftelK AKA | lld:pubmed |
| pubmed-article:7278079 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:7278079 | pubmed:day | 17 | lld:pubmed |
| pubmed-article:7278079 | pubmed:volume | 59 | lld:pubmed |
| pubmed-article:7278079 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:7278079 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:7278079 | pubmed:pagination | 877-88 | lld:pubmed |
| pubmed-article:7278079 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:7278079 | pubmed:meshHeading | pubmed-meshheading:7278079-... | lld:pubmed |
| pubmed-article:7278079 | pubmed:meshHeading | pubmed-meshheading:7278079-... | lld:pubmed |
| pubmed-article:7278079 | pubmed:meshHeading | pubmed-meshheading:7278079-... | lld:pubmed |
| pubmed-article:7278079 | pubmed:meshHeading | pubmed-meshheading:7278079-... | lld:pubmed |
| pubmed-article:7278079 | pubmed:meshHeading | pubmed-meshheading:7278079-... | lld:pubmed |
| pubmed-article:7278079 | pubmed:meshHeading | pubmed-meshheading:7278079-... | lld:pubmed |
| pubmed-article:7278079 | pubmed:meshHeading | pubmed-meshheading:7278079-... | lld:pubmed |
| pubmed-article:7278079 | pubmed:meshHeading | pubmed-meshheading:7278079-... | lld:pubmed |
| pubmed-article:7278079 | pubmed:meshHeading | pubmed-meshheading:7278079-... | lld:pubmed |
| pubmed-article:7278079 | pubmed:meshHeading | pubmed-meshheading:7278079-... | lld:pubmed |
| pubmed-article:7278079 | pubmed:meshHeading | pubmed-meshheading:7278079-... | lld:pubmed |
| pubmed-article:7278079 | pubmed:meshHeading | pubmed-meshheading:7278079-... | lld:pubmed |
| pubmed-article:7278079 | pubmed:year | 1981 | lld:pubmed |
| pubmed-article:7278079 | pubmed:articleTitle | Neutropenia after penicillins: toxic or immune-mediated? | lld:pubmed |
| pubmed-article:7278079 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7278079 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7278079 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7278079 | lld:pubmed |
